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Fournier’s gangrene is a rare process which aﬀects soft tissue in the genital and perirectal area. It can also progress to all diﬀerent
stages of sepsis, and abdominal compartment syndrome can be one of its complications. Two patients in septic shock due to
Fournier gangrene were admitted to the Intensive Care Unit of Emergency Department. In both cases, infection started from the
scrotumandthenecrosisquicklyinvolvedgenitals,perineal,andinguinalregions.Patientsweretreatedwithsurgicaldebridement,
protective colostomy, hyperbaric oxygen therapy, and broad-spectrum antibacterial chemotherapy. Vacuum-assisted closure
(VAC) therapy was applied to the wound with the aim to clean, decontaminate, and avoid abdominal compartmental syndrome
development. Both patients survived and were discharged from Intensive Care Unit after hyperbaric oxygen therapy cycles and
abdominal closure.
1.Introduction
Fournier’s gangrene is a rare necrotizing fasciitis of the per-
ineal, genital, or perianal regions [1]. It is characterized by
obliterative endarteritis and thrombosis of the subcutaneous
arteries resulting in gangrene of the subcutaneous tissue
and overlying skin. Tissue damage may extend to the penis,
anteriorabdominalwall,buttocks,orthighs[2,3].Fournier’s
gangrene usually starts with perianal or perineal pain, which
is often disproportionate to the physical ﬁnding such as
swelling or pruritus in the aﬀected area. The disease is not
limited to young individuals, nor is it limited to men [4].
In most cases, Fournier’s gangrene is a polymicrobial, syner-
gistic,andnecrotizinginfectionoftheperinealsubcutaneous
fascia and male genitalia that originates from the skin, ure-
thra, or rectum. The most commonly found microorganisms
are E. coli, Bacteroides, Staphylococcus, Proteus, Streptococ-
cus, Pseudomonas, and Enterococcus [5–7].
Patientsaﬀectedmaypresentfever,malaiseforafewdays,
nonspeciﬁc abdominal pain, and general symptoms of infec-
tions without any speciﬁc symptoms from the perineal area.
Depending upon the degree of progression, the skin may
look normal, red, or shiny in appearance or may show evi-
dence of ecchymosis, crepitus, or gangrene [6–8]. Advanced
age (over 50 years old), obesity, diabetes mellitus, peripheral
vascular disease, local trauma, urethral stricture, malignant,
andperianaldiseasehavebeenreportedasmainpredisposing
factors [9]. The disease can no longer be considered to be
idiopathic, as reported in Fournier’s original article [10]. In
most of cases, an urologic, colorectal, or cutaneous source
can be identiﬁed [11]. The disease is no longer prevalent
in the younger members of the population, and an analysis
clearly revealed a male predominance and a mean age over
50 years [10, 11].
There is a worldwide consensus that immediate radical
excision of the gangrene should be accompanied by intensive2 Case Reports in Anesthesiology
care measures in patients with Fournier’s Gangrene. Treat-
ment must include the application of sepsis management
guidelines [12], and, where available, hyperbaric oxygen
therapy is highly recommended [13].
HerewereporttwocasesofsepticshockduetoFournier’s
gangrenewhichrecoveredwell,treatedwithsurgicaldebride-
ment, hyperbaric oxygen therapy, and vacuum-assisted clo-
sure (VAC) therapy.
2. Case Presentation
The patients described here were both admitted to the Inten-
sive Care Unit (ICU) of the Referral Center for Hyper-
baric Oxygen Therapy (Careggi Teaching Hospital, Florence,
Italy). The patients’ data were recorded in our ICU-database
(FileMakerPro5.5v2,FileMaker,Inc,USA).Foreachpatient,
demographic, clinical characteristics and laboratory param-
eters were collected(Table 1). Written, informed consent was
obtained from the patients for publication and accompany-
ing images.
During ICU stay, intraabdominal pressure was moni-
tored by using a urinary bladder pressure gauge (AbViser,
Wolfe Tory Medical Inc., Salt Lake City, Utah) in supine
patients; every 4 hours, 50mL of saline solution was instilled
in the urinary bladder closed system. VAC device used (KCI,
San Antonio, TX, USA) is a polyurethane sponge cut to the
appropriate size placed over the wound. The sponge, with
an 18-F suction tube, is covered with second sterile adherent
occlusive dressing. Suction is applied to the sponge using a
portable pump. The dressing needs to be changed every 24–
72 hours.
2.1. Case 1. A 63-year-old man was transferred to our ICU
fromaperipheralhospitalwithadiagnosisofFournier’sgan-
grene. Initial symptoms had started one week before patient
presentation at the peripheral emergency department. At
our ICU admission, the patient was in septic shock, and
infection involved all the scrotum, genitals, perineal, and
inguinal regions. No predisposing conditions were found.
Empiric wide broad antimicrobial therapy was administered
(tigecycline, ertapenem, and metronidazole), and vasoactive
support was needed. The patient immediately underwent
wide surgical debridement (Figure 1), and VAC therapy was
appliedonthewound(Figure 2).Orchidectomywasnotnec-
essary. Hyperbaric oxygen therapy (20 minutes each at
2.4ATA, 100% FiO2) was started after surgical toilette. Dur-
ing the sixth wound dressing, surgical colostomy was needed
in order to limit the possibility of superinfection in anorectal
area. The patient underwent 22 days of VAC therapy and
14 hyperbaric oxygen therapy sessions. 24 days after ICU
admission, the patient was discharged to a high-dependency
unit. Reconstructive surgery was later performed with good
results.
2.2. Case 2. A 75-year-old man presenting dyspnoea, hy-
potension, and tachycardia was admitted to the emergency
department of a peripheral hospital. An abscess was found in
therightglutenwithnecrosisintheperianalandsacralareas,
Table 1: Baseline and clinical characteristics of patients.
Patient 1 Patient 2
Gender Male Male
Age (years) 63 75
BMI 23 29
SAPS II admission/discharge 47/24 42/22
SOFA admission/discharge 10/6 10/7
White cells count (N/mm3) 1,200 18,900
Platelet count (N/mm3) 54,000 331,000
Lactate dehydrogenase (U/l) 137 241
Creatine kinase (U/l) 61 20
Procalcitonin (ng/mL) 20.9 1.1
Duration of VAC therapy (days) 22 3
Duration of mechanical ventilation (days) 12 2
Length of stay in ICU (days) 23 4
SAPS: Simpliﬁed Acute Physiology Score; SOFA: Sequential Organ Failure
Assessment Score; VAC: Vacuum-assisted closure.
Figure 1
and rectal ﬁstula. A computed tomography scan revealed
gas formation on the pelvic cavity, on the right gluten and
behindthecorporacavernous.Fournier’sgangrenediagnosis
was then made. The patient presented many risk and pre-
disposing factors in his medical history: diabetes, chronic
obstructive pulmonary disease, dilated cardiomiopathy, and
chronic viral hepatitis. Before transfer to our ICU, empiric
antimicrobial therapy withpiperacillin/tazobactam, metron-
idazole, and vancomycin was initiated. After ICU admission,
the patient immediately underwent surgical debridement.
During surgical intervention, ileostomy was decided to iso-
late the rectal site of infection. VAC therapy was applied on
the wound at the end of the surgical procedure, and hyper-
baric oxygen therapy was started the next day. VAC device
was removed after three days, and the patient was discharged
to the postintensive ward the day after.
3. Discussion
T h et w oc a s e sr e p o r t e dw e r ed i ﬀerent in disease stadium
and length of treatment. The most important feature in
Fournier’s gangrene management remains the timing of
diagnosis; in the ﬁrst case, the infection started one week
before. This might cause the need for prolonged VAC ther-
apy and numerous hyperbaric oxygen therapy sessions, inCase Reports in Anesthesiology 3
Figure 2
addition to wide surgical debridement. The early treatment
performed in the second case permitted more conservative
surgical intervention and lower duration of VAC therapy,
hyperbaric oxygen therapy sessions, and ICU length of stay.
Despite appropriate treatment, mortality rates remain
high, up to 67% [14], even if a recent article by Janane and
coworkersreported,inacaseseriesof70patientstreatedwith
both VAC therapy and hyperbaric oxygen therapy, a very low
mortality rate (11.4%), failing also to conﬁrm the predictive
valueofFournier’sgangreneseverityscoreindex[15].Unfor-
tunately, this report is available only in Spanish, thus, im-
portant details about this wide sample are unknown for
many readers. Another case treated with both VAC devices
hyperbaric oxygen therapy has been recently published by
Assenza and coauthors [16].
As well as hyperbaric oxygen therapy [13], we suppose
that the use of VAC devices can increase ﬁbroblast migration
and cell proliferation improving clinical outcome. We do not
know if oxygen penetrates the plastic drape, but it might be
reasonable that hyperbaric oxygen therapy can have more
beneﬁcial eﬀects if combined with the reduction of edema
and interstitial pressure, thanks to VAC dressing. When an-
alyzing this kind of therapy in a relatively rare disease, the
diﬃculty is that prospective randomized trials do not exist,
and the limited number of patients in each study cannot
allow strong statistical comparisons. Nevertheless, hyper-
baric oxygen therapy has been demonstrated to reduce mor-
tality rate in several case series [13]. Moreover, Cuccia and
coworkers recently reported the good resolution of six cases
treated with VAC therapy after surgical debridements [17].
In a recent prospective, comparative studies on 35 patients
showed that patients treated with VAC device had a signiﬁ-
cantly lower mortality than patients in which daily antiseptic
(polyhexanide) dressings were used [18].
Both of the patients presented in this paper under-
went colostomy. The rationale for rectal diversion includes
a decrease in the number of germs in the perineal region,
improved wound healing, and local control of the infection
[19]. Many surgeons believe that a colostomy is an integral
partofmanagementforpatientsrequiringextensivedebride-
ment, especially if the infection arises in the anorectal region
[6, 8]. Other authors recommend that a diverting colostomy
should only be constructed in the presence of colorectal
perforation,immunodepression,orifincontinenceispresent
[20].
In addition, both patients were treated with Flexi-Seal
Fecal Management System (Conva Tec USA, Skillman, New
Jersey) for rectal diversion, which, for some authors, helps
avoid the complications of performing a colostomy and sub-
sequent reconstruction. The Flexi-Seal Fecal Management
System consists of a soft silicone catheter with a retention
balloon that is inserted into the rectum, a syringe for rectal
irrigation,andacollectionbag.Itwasdesignedtodivertfecal
matter in patients with diarrhea and skin ulcers in order to
protect the wounds from contamination, especially in the
intensive care unit setting [21].
4. Conclusions
Far from giving solid evidence regarding Fournier’s gangrene
treatment, our experience may suggest the consideration
of the association of surgical treatment, VAC therapy, and
sequential hyperbaric treatment for this life-threatening dis-
ease.Duetothelackoflargestudies,moremedicalliterature,
even in the form of case series, is needed to help clinicians.
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